藥物成份

共有 21216 個藥物成份

Meloxicam contains not less than 99.0% and not more than 101.0% of C14H13N3O4S2, calculated on the dried substance.

• 關聯藥證數量: 1

Membrane coated with rabbit anti-HCG antibodies and colored colloidal gold-monoclonal mouse anti-HCG antibodies conjugated, conjugated pad with reagent and wicking pad without reagent.

• 關聯藥證數量: 1

Membrane coated with rabbit anti-hCG antibodies and colored colloidal gold-monoclonal mouse anti-hCG antibodies conjugated, conjugated pad with reagent and wicking pad without reagent.

• 關聯藥證數量: 1

Membrane coated with rabbit anti-mouse poly-antibodies and mouse anti-LH monoclonal antibodies, conjugate pad with colloidal gold-monoclonal mouse anti-LH antibodies, wicking pad without reagent.

• 關聯藥證數量: 1

Menotrophin

• 關聯藥證數量: 1

Menthol is an alcohol obtained from oils derived from a variety of mints. Menthol is levorotatory (l-menthol) from natural. It contains NLT 98.0% and NMT 102.0% of menthol (C10H20O).

• 關聯藥證數量: 1

Mephenoxalone contains not less than 98.0% and not more than 102.0% of C11H13NO4,calculated with reference to the dried substance.

• 關聯藥證數量: 1

Meprobamate contains 97.0%~101.0% (dried basis)

• 關聯藥證數量: 1

Mequitazine contains not less than 98.5% of C20H22N2S, calculated on the dried basis.

• 關聯藥證數量: 1

Mequitazine contains not less than 98.5% of mequitazine(C20H22N2S), calculated on the dried basis.

• 關聯藥證數量: 1

Mequitazine,when dried,contains not less than 98.5% of C20H22N2S.

• 關聯藥證數量: 1

Mercuric nitrate 0.087 mmol/L\nMercuric thiocyanate 1.75 mmol/L\nMercuric chloride 0.74 mmol/L\nNitric acid (conc.) 0.135%\nSulfuric acid (conc.) 0.05%\nFerric nitrate 22.3 mmol/L\n

• 關聯藥證數量: 1

Meropenem and Sodium Carbonate is a sterile dry mixture of Meropenem and Sodium Carbonate. It contains not less than 70.0 percent and not more than 78.0 percent of meropenem (C17H25N3O5S), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Meropenem contains not less than 75.0% and not more than 85.0% of C17H25N3O5S calculated on the dried basis.

• 關聯藥證數量: 1

Meropenem contains not less than 98.0 percent and not more than 101.0 percent of C17H25N3O5S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Meropenem trihydrate equivalent to Meropenem 250mg、500mg(potency)\n(with excipient sodium carbonate)

• 關聯藥證數量: 1

Mesalazine (Mesalamine) contains NLT 98.5% and NMT 101.5% of C7H7NO3, calculated on the dried basis.

• 關聯藥證數量: 1

Mesalazine (Mesalamine) contains not less than 98.5% and not more than 101.5% of C7H7NO3, calculated on the dried substance.

• 關聯藥證數量: 1

Mesna contain 96.0%~102.0% of C2H5NaO3S2, calculated on the dried basis.

• 關聯藥證數量: 1

Mesna contains not less than 96.0 % and not more than 102.0 % of C2H5NaO3S2, calculated on the dried substance.

• 關聯藥證數量: 1

Mesna contains not less than 96.0% and not more than 102.0% of C2H5NaO3S2, calculated on dried basis.

• 關聯藥證數量: 1

Mesulphen Assay: Not less than 23.5% and not more than 26.5% of sulfur (S:32.07)

• 關聯藥證數量: 1

Mesulphen Assay: Not less than 23.5% and not more than 26.5% of sulfer (S:32.07)

• 關聯藥證數量: 1

Metamizole Sodium , when calculated on the dried substance, contains not less than 99% and not more than 101% of C13H16N3NaO4S.

• 關聯藥證數量: 1

Metamizole Sodium contains not less than 99.0% and not more than the equivalent of 100.5% C13H16N3NaO4S,calculated with reference to the dried substance.

• 關聯藥證數量: 1

Metamizole Sodium, when calculated on the dried substance, contains not less than 99% and not more than 101% of C13H16N3NaO4S.

• 關聯藥證數量: 1

Metaxalone contains not less than 98.0 percent and not more than 102.0 percent of C12H15NO3

• 關聯藥證數量: 1

Metfomin Hydrochloride contains not less than 98.5% and not more than 101.0% of C4H11N5 HCl, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Metformin HCL contains NLT 99.0% and NMT 101.0% of C4H12N5Cl, calculated on the dried basis.

• 關聯藥證數量: 1

Metformin HCl contains not less than 98.5% and not more than 101.0% of C4H11N5.HCl, calculated on the dried substance.

• 關聯藥證數量: 1

Metformin HCl contains not less than 98.5% and not more than 101.0% of C4H12CIN5, calculated on the dried basis.

• 關聯藥證數量: 1

Metformin HCl contains not less than 98.5% and not more than 101.0% of C4H12ClN5 calculated with reference to the dried substance.

• 關聯藥證數量: 1

Metformin Hydrochloride Assay: 98.5%-101.0% on dried basis

• 關聯藥證數量: 1

Metformin Hydrochloride 98.5 per cent to 101.0 per cent (dried substance).

• 關聯藥證數量: 1

Metformin Hydrochloride (Process 2) (C4H12ClN5) Content: 98.5% to 101.0% (dried substance).

• 關聯藥證數量: 1

Metformin Hydrochloride contains 98.5%~101.0% of C4H11N5．HCl, calculated on the dried basis.

• 關聯藥證數量: 1

Metformin Hydrochloride contains not less than 98.0 % and not more than 102.0 % of C4H11N5‧HCl, calculated on the dried basis.

• 關聯藥證數量: 1

Metformin Hydrochloride contains not less than 98.5% and not more than 101.0% of C4H11N5,HCl, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Metformin Hydrochloride contains not less than 98.5% and not more than 101.0% of C4H12ClN5 (dried substance).

• 關聯藥證數量: 1

Metformin Hydrochloride contains not less than 98.5% and not more than 101.0% of C4H12ClN5, calculated on anhydrous substance.

• 關聯藥證數量: 1

Metformin Hydrochloride contains not less than 98.5% and not more than 101.0% of C4H12ClN5, calculated on the dried substance.

• 關聯藥證數量: 1

Metformin Hydrochloride contains not less than 99.0% and not more than 101.0% of C4H12N5Cl, calculated on the dried substance.

• 關聯藥證數量: 1

Metformin hydrochloride contains not less than 98.5% and not more than 101.0% of C4H12ClN5, calculated on the dried substance.

• 關聯藥證數量: 1

Methadone Hydrochloride contains 99.0% to 101.0% of Methadone Hydrochloride (C21H28ClNO), calculated on the dried substance.

• 關聯藥證數量: 1

Methadone Hydrochloride contains not less than 98.5 % and not more than 100.5 % of C21H27NO.HCl, calculated on the dried basis.

• 關聯藥證數量: 1

Methadone Hydrochloride contains not less than 99.0 percent and not more than 101.0 percent of C21H28ClNO, calculated on the dried basis.

• 關聯藥證數量: 1

Methadone Hydrochloride contains not less than 99.0% and not more than 101.0% of C21H27NO‧HCl, calculated on the dried substance.

• 關聯藥證數量: 1

Methisoprinol contains not less than 95.0% and not more than 105.0% of C52H78N10O17 calculated on the dried basis.

• 關聯藥證數量: 1

Methocarbamol contains not less than 98.5% and not more than 101.5% of C11H15NO5, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Methoxyphenamine HCL contains not less than 98% and not more than 102% of C11H17NO.HCL, calculated on the dried basis.

• 關聯藥證數量: 1

Methyl Methacrylate.....97.6%\nN-N dimethyl-p-toluidine.....2.4%\nHydroquinone.....20ppm\n以下空白

• 關聯藥證數量: 1

Methyl polymethacrylate.....64.4%\nBenzoyl peroxide.....0.6%\nBarium Sulfate.....25%\nHydroxyapatite.....10%\n以下空白

• 關聯藥證數量: 1

Methyldopa contains not less than 98.5% and not more than 101.0% of C10H13NO4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Methyldopa contains not less than 98.5% and not more than 101.0% of C10H13NO4‧3/2H2O calculated on anhydrous basis.

• 關聯藥證數量: 1

Methylene diphosphonate

• 關聯藥證數量: 1

Methylparaben

• 關聯藥證數量: 1

Methylphenidate HCl contains 98.0% to 102.0%, of (C14H19NO2‧HCl), calculated on the anhydrous basis.

• 關聯藥證數量: 1

Methylphenidate Hydrochloride contains not less than 98.0% and not more than 102.0% of C13H18N2O, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Methylphenidate hydrochloride Content: 99.0 per cent to 101.0 per cent (dried substance).

• 關聯藥證數量: 1

Methylprednisolone 11β,17,21-Trihydroxy-6 α -methylpregna-1,4-diene-3,20-dione. Content:97.0% to 103.0%(dried substance).

• 關聯藥證數量: 1

Methylprednisolone content：97.0 percent to 102.0 percent (dried substance)

• 關聯藥證數量: 1

Methylprednisolone contains not less than 97% and not more than 103% of C22H30O5 on dried substance.

• 關聯藥證數量: 1

Methylprednisolone contains not less than 97.0 percent and not more than 103.0 percent of C22H30O5, calculated on the dried basis.

• 關聯藥證數量: 1

Methylprednisolone contains not less than 97.0% and not more than 103.0% of C22H30O5, calculated on the dried basis.

• 關聯藥證數量: 1

Methylprednisolone sodium succinate, 97.0-103.0% w/w

• 關聯藥證數量: 1

Methyltestosterone contains NLT 97.0% and NMT 103.0% of methyltestosterone (C20H30O2), calculated on the dried basis.

• 關聯藥證數量: 1

Methyltestosterone contains not less than 97.0% and not more than 103.0% of C20H30O2, calculated on the dried basis.

• 關聯藥證數量: 1

Metoclopramide (4-Amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide.)\nContent not less than 99.0% and not more than 101.0% (dried substance).

• 關聯藥證數量: 1

Metoclopramide Hydrochloride contains not less than 99.0 per cent and not more than the equivalent of 101.0 per cent of C14H24ClN3O3,HCl calculated with reference to the anhydrous substance.

• 關聯藥證數量: 1

Metoclopramide Hydrochloride contains not less than 99.0% and not more than 101.0% of C14H23Cl2N3O2, H2O, calculated with reference to the anhydrous substance.

• 關聯藥證數量: 1

Metoclopramide hydrochloride contains not less than 99.0% and not more than 101.0% of C14H22C1N3O2,HC1,H2O, calculated on the dried basis.

• 關聯藥證數量: 1

Metoclopramide hydrochloride contains not less than 99.0% and not more than 101.0% of C14H22ClN3O2●HCl, calculated with reference to the anhydrous substance.

• 關聯藥證數量: 1

Metolazone contains not less than 97.0% and not more than 102.0% C16H16ClN3O3S, calculated with reference to the dried substance.

• 關聯藥證數量: 1

Metoprolol Succinate contains not less than 98.0 percent and not more 102.0 percent of (C15H25NO3)2‧C4H6O4, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Metoprolol Succinate contains not less than 98.0 percent and not more than 102.0 percent of (C15H25NO3)2？C4H6O4, calculated on the dried basis.

• 關聯藥證數量: 1

Metoprolol Succinate contains not less than 99.0% and not more than 101.0% of C34H56N2O10, calculated on the dried substance.

• 關聯藥證數量: 1

Metoprolol Tartrate contains not less than 99.0 and not more than 101.0% of C34H56N2O12, calculated on the dried substance.

• 關聯藥證數量: 1

Metronidazole contains not less than 99.0% and not more than 101.0% of C6H9N3O3 calculated on the dried basis.

• 關聯藥證數量: 1

Metronidazole contains not less than 99.0% and not more than 101.0% of C6H9N3O3, calculated on dried substance.

• 關聯藥證數量: 1

Metronidazole contains not less than 99.0% and not more than 101.0% of C6H9N3O3, calculated on the dried basis.

• 關聯藥證數量: 1

Metronidazole contains not less than 99.0% and not more than 101.0% of C6H9N3O3, calculated on the dried substance.

• 關聯藥證數量: 1

Metronidazole contains not less than 99.0% and not more than 101.0% of metronidazole(C6H9N3O3), calculated on the dried basis.

• 關聯藥證數量: 1

Metronidazole contains not less than 99.0% of C6H9N3O3,calculated on the dried basis.

• 關聯藥證數量: 1

Mexiletine Hydrochloride contains not less than 99.0% and not more than 101.0% of C11H18ClNO, calculated on the anhydrous substance.

• 關聯藥證數量: 1

Mg　Stearate

• 關聯藥證數量: 1

Micafungin Sodium contains not less than 97.0 percent and not more than 102.0 percent of C56H70N9NaO23S, calculated on the anhydrous basis.

• 關聯藥證數量: 1

Miconazole Nitrate contains not less than 98.0% and not more than 102.0% of C18H14Cl4N2O.HNO3,calculated on the dried basis.

• 關聯藥證數量: 1

Miconazole contains not less than 98.0 percent and more than 102.0 percent of C18H14Cl4N2O, calculated on the dried basis.

• 關聯藥證數量: 1

Micro Albumin control 1 (Target Range：20~40 μg/ml) 2 bottles x 2 ml\nMicro Albumin control 2 (Target Range：75~105 μg/ml) 2 bottles x 2 ml\ncontains purified human serum albumin and 0.09% sodium azide.

• 關聯藥證數量: 1

Micro-ELISA trays, Serum control; lyophilized anti-HLA alloantiserum (use for positive and negative control wells), Sterile deionized water (use for reconstitution of serum control), Alkaline phosphate (AP) conjugated anti-human IgG, Antibody diluent, Wash buffer, Colorimetric enzyme substrate: BCIP, components A and B (Blue PhosTM from KPL), and Stop reagent

• 關聯藥證數量: 1

Microelisa strip plate: Holder with 96 wells each coated with synthetic EBV EBNA-1 peptide.\nConjugate: HRP-labeled Anti-human IgG (goat).\nConjugate diluent: Phosphate buffer.\nCalibrator I : Human serum containing 5 AU anti-EBNA IGg/ml (nonreactive level).\nCalibrator II : Human serum containing 20 AU anti-EBNA IGg/ml (cut-off level).\nCalibrator III : Human serum containing 110 AU anti-EBNA IGg/ml (reactive level).\nCalibrator IV : Human serum containing 200 AU anti-EBNA IGg/ml (high reactive level).\nSample Diluent: Phosphate buffer.\nPhosphate buffer concentrate: Concentrated (25x) phosphate buffer with 0.05% tween-20.\nTMB substrate: Tetramethylbenziden and peroxide in citrate buffer.\nStop Solution: 0.2 mol/l sulfuric acid.

• 關聯藥證數量: 1

Microelisa strip plate：Holder with 96 wells each coated with monoclonal anti-human IgM (mouse)\nConjugate：Monoclonal anti-VCA p18 (rat) conjugated with horseradish peroxiase.\nConjugate diluent：Synthetic VCA peptide in MES buffer (lyophilized).\nReconstitution solution：Deionized water.\nCalibrator I：Human serum containing 5 AU anti-VCA p 18 IgM/ml (nonreactive level).\nCalibrator II：Human serum containing 20 AU anti-VCA p 18 IgM/ml (cut-off level).\nCalibrator III：Human serum containing 80 AU anti-VCA p 18 IgM/ml (reactive level).\nCalibrator IV：Human serum containing 140 AU anti-VCA p 18 IgM/ml (high reactive level).\nSample Diluent：Phosphate buffer. Preservative：Pro Clin 300 (0.2%).\nPhosphate buffer concentrate：Concentrated (25x) phosphate buffer with 0.05% tween-20.\nTMB substrate：Tetramethylbenzidine and peroxide in citrate buffer.\nStop Solution：0.2 mol/l sulfuric acid.

• 關聯藥證數量: 1

Micronised aclidinium bromide

• 關聯藥證數量: 1

Microparticles: 1 Bottle (6.6 mL per 100 test bottle/27.0 mL per 500 test bottle)\nAnti-tacrolimus coated microparticles in EDTA buffer with protein stabilizer.\nMinimum Concentration: 0.09% solids. Preservatives: sodium azide and ProClin 950.\nConjugate: 1 Bottle (7.8 mL per 100 test bottle/16.0 mL per 500 test bottle)\nTacrolimus acridinium-labeled conjugate in citrate buffer with protein stabilizer.\nMinimum Concentration:5.0 ng/mL. Preservative: ProClin 300.\nAssay Diluent: 1 Bottle (8.9 mL per 100 test bottle/45.8 mL per 500 test bottle)\nAssay Diluent containing MES buffer and sodium chloride. Preservatives: ProClin 950 and ProClin 300.\nCalibrators\n6 Bottles (Calibrator A 9.0 mL, Calibrators B-F 4.5 mL each) of ARCHITECT\nTacrolimus Calibrators. The calibrators yield the following concentrations: 0, 3, 6, 12, 20, 30 ng/ml.\nWhole Blood Precipitation Reagent\n1 Bottle (20.4 mL) ARCHITECT Tacrolimus Whole Blood Precipitation Reagent containing zinc sulfate solution in methanol and ethylene glycol.。處方變更為：空白。

• 關聯藥證數量: 1

Microparticles：1 or 4 Bottles (8.0 mL each) Anti-cyclosporine coated microparticles in MOPS buffer with protein stabilizers.\n

• 關聯藥證數量: 1

Micropiate wells:12 microplate strips each containing 8 individual break-off wells in a frame, Calibrator:(IgM, human), Positive control:(IgM, human), Neagtive control:(IgM, human), Enzyme conjugate:peroxidase-labelled anti-human IgM (goat), Sample buffer:containing IgG/RF-Absorbent (Anti-human IgG antibody preparation obtained from goat), Wash bufferChromogen/substrate solution:TMB/H2O2, Stop solution:sulphuric acid.

• 關聯藥證數量: 1

Microplate 12strips/6strips\nEnzyme Conjugate 25ml/12ml\nPositive Control 4ml\nNegative Control 4ml\nSpecimen Dilution Buffer 110ml\nWash Buffer 110ml\nColor Substrate 25ml\nStop Solution 6ml\n

• 關聯藥證數量: 1

Microplate Strips (coated with a synthetic SmD peptide antigen).\nCalibrators (Sm antibody calibrators at concentrations of -3--7-19-40-100 U/ml in PBS containing BSA, 0.095% (w/v) sodium azide, detergent and human serum).\nPositive Control (containing BSA, 0.095% (w/v) sodium azide, detergent and human serum).\nNegative Control (containing BSA, 0.095% (w/v) sodium azide, detergent and human serum). \nWash Buffer Concentrate (20x PBS concentrate containing 0.095% (w/v) sodium azide and detergent).\nSample Diluent (PBS containing BSA, 0.095% (w/v) sodium azide and detergent). \nIgG HRP Conjugate (anti-human IgG HRP conjugate).\nSubstrate TMB (3, 3’, 5, 5’Tetramethylbenzidine).\nStop Solution (0.5M H2SO4).

• 關聯藥證數量: 1

Microplate Strips (coated with bovine cardiolipin and bovine β-glycoprotein I as cofactor). \nCalibrators (cadiolipin IgG antibody calibrators at concentrations of 0-4-8-20-40-100 GPL-U/ml in PBS containing BSA and human serum). \nPositive Control (conatining BSA, detergent and human serum).\nNegative Control (cotaining BSA, detergent and human serum). \nWash Buffer Concentrate (20x PBS concentrate).\nSample diluent (PBS containing BSA).\nIgG HRP Conjugate (anti-human IgG HRP conjugate) Substrate TMB(3,3,5,5 Tetramethylbenzidine).\nStop Solution (0.5 M H2SO4).

• 關聯藥證數量: 1

Microplate Strips (coated with human purified MPO antigen)\nCalibrators (at concentrations of 0 - 3 -7 - 16 - 40 - 100 U/ml in PBS)\nPositive Control\nNegative Control\nWash Buffer Concentrate (20x PBS)\nSample Diluent (PBS)\nIgG HRP Conjugate (anti-human IgG HRP (horse-radish peroxidase) conjugate)\nSubstrate TMB\nStop Solution (0.5 M H2SO4)

• 關聯藥證數量: 1